RNAi’s Future in Drug-Target Screening – The Scientist
The Scientist |
RNAi's Future in Drug-Target Screening
The Scientist RNAi's Future in Drug-Target Screening. A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? By Catherine Offord | April 17, 2017. |
